Home
About Us
Team
Investment Approach
Portfolio
Impact
News & Media
Contact
Investor Relations
Home
About Us
Team
Investment Approach
Portfolio
Impact
News & Media
Contact
Investor Relations
•
By
somerse_wp-capital
•
In
News
•
Tag:
Globela
,
Pharma
•
0
Somerset invests in Gujarat-based bulk drug firm in first pharma bet
Somerset Indus Capital Partners
>
News
>
Somerset invests in Gujarat-based bulk drug firm in first pharma bet
0
Shares
Globela
Pharma
Recent News
Crisil assigns Fund Management Grading – 1 to Somerset Indus Healthcare India Fund III – Scheme I
May 7, 2025
By
somerse_wp-capital
Somerset Bets on Medical Devices Maker “Cyrix Healthcare” In Maiden Deal from Third Fund
December 10, 2024
By
somerse_wp-capital
Impact and Sustainability Report – Somerset Indus Capital – March 2024
October 7, 2024
By
somerse_wp-capital
Tag Cloud
Apex
Browndove
Cygnus
Cyrix
Diagnostics
Digital Health
EICU
Express
Fund
Genworks
Globela
Healthcare Delivery
Hexagon
Hospitals
IPO
Krsnaa
Medical devices
Medtech
Nutrition
Packaging
Pharma
Printmann
Prognosys
Sandor
Somerset
Wellness
Recent Cases
Previous Post
THE NEXT OPPORTUNITY IN HEALTHCARE IS SPELT ‘TECHNOLOGY’
Next Post
Globela Pharma – A Somerset Portfolio Company
Related Posts
February 20, 2024
Somerset Invests in Printmann Offset; Marks full deployment of Fund II
By
somerse_wp-capital
In
News
0
May 27, 2022
India wants to be the ‘pharmacy of the world.’ But first, it must wean itself from China
By
somerse_wp-capital
In
News
0
November 16, 2021
Globela Pharma – A Somerset Portfolio Company
By
somerse_wp-capital
In
News
0
